Quantcast

FDA APPROVES QUTENZA(TM), FIRST AND ONLY PRESCRIPTION STRENGTH CAPSAICIN PRODUCT FOR PAIN REDUCTION

November 16, 2009

The U.S. Food and Drug Administration (FDA) has approved Qutenza, a new
prescription patch applied to the skin for one hour for reduction of
post-shingles nerve pain. Qutenza is the first and only prescription strength
capsaicin product. Qutenza contains a manmade form of capsaicin, the
substance in chili peppers that gives them their heat sensation.

After a single one-hour application, directly to the site of pain,
Qutenza may reduce post shingles nerve pain for up to 12 weeks. Qutenza is
applied by a doctor or healthcare professional. Qutenza can be used alone or
with other pain medications and is unlikely to cause drug-drug interactions.

* Each year, about a million Americans develop shingles, a painful virus
infection related to chicken pox.

* Up to one in five people with shingles will experience prolonged pain
due to a complication called postherpetic neuralgia (PHN).

o PHN is a chronic condition that is the result of nerve damage caused by
the shingles virus.

o The pain can persist long after the characteristic rash clears up and
can disrupt sleep, mood, work and activities of daily living.

o The risk of developing PHN increases with age, especially in people
over 50, and for patients who experienced severe pain or severe rash during
the acute shingles episode.

    Please see full prescribing information at www.qutenza.com.

    SATELLITE FEEDS:
    Monday, November 16th, 2009        Tuesday, November 17th, 2009
    7:30 PM - 7:45 PM ET               3:00 AM - 3:15 AM ET
    Galaxy 19                          Galaxy 19
    C-Band                             C-Band
    Transponder 20                     Transponder 20
    Downlink Freq. 4100 Horizontal     Downlink Freq. 4100 Horizontal

    Tuesday, November 17th, 2009
    1:00 PM - 1:15 PM ET
    AMC 3
    C-Band
    Transponder 3
    Downlink Freq. 3760 Horizontal

NEWS: FDA Approves Qutenza, the first and only prescription strength
treatment with capsaicin, the “hot ingredient in chili peppers. Qutenza can
provide 12 Weeks of pain reduction from a single one hour treatment for
post-shingles pain

FORMAT: B-roll and Soundbites

ADDITIONAL RESOURCES: Video, contact information and more available at:
http://multivu.prnewswire.com/broadcast/40932/press.html


    SOUNDBITES:
    * Tony DiTonno - Chief Executive Officer, NeurogesX, Inc.
    * Lynn R. Webster, M.D., F.A.C.P.M., F.A.S.A.M. - Medical Director,
      Lifetree Clinical Research, Salt Lake City, Utah

    B-ROLL INCLUDES:
    * Doctor and patient in examination room
    * Product shot
    * Process for application and removing of dermal system
    * Chili peppers
    * Product and Company logos

VIDEO PROVIDED BY: NeurogesX

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations,
1-800-653-5313 EXT. 3

SOURCE NeurogesX


Source: newswire



comments powered by Disqus